BCM
DPLO

Bienville Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bienville Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,000
Closed -$274K – 100
2014
Q4 		$274K Buy
+10,000
New +$243K 0.23% 66

Other funds holding DPLO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bienville Capital Management's DPLO Position: Q1 2015 in Review

Bienville Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2015, closing a stake of 10,000 shares — an estimated $274K sold.

Bienville Capital Management first reported a position in DPLO in Q4 2014 and held it in 1 quarter. The position peaked at $274K in Q4 2014. 101 funds tracked by Wall St. Rank hold DPLO as of Q1 2015.

  • Bienville Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2015 after selling out during the quarter.
  • Bienville Capital Management sold 10,000 DIPLOMAT PHARMACY, INC. shares in Q1 2015, an estimated $274K.
  • Bienville Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 1 quarter.
  • Bienville Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $274K in Q4 2014.
  • 101 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2015.

Based on Bienville Capital Management's 13F filing for Q1 2015, filed 13 May 2015.